Big Pharma companies are in a rush to buy biotech firms. Why? They face a huge problem. Many of their top-selling drugs will soon lose patent protection. This is called the "patent cliff. " By 2032, they could lose over $170 billion in sales. To avoid this, they need new drugs fast. That's where bi
In the world of medical research, a new player has emerged that could change the game for people with a tough type of blood cancer called acute myeloid leukemia (AML). This cancer is notorious for being resistant to many treatments, especially in cases with complex genetic issues like MECOM rearrang
Lipoprotein(a), or Lp(a) for short, is a sneaky little molecule lurking in your bloodstream. Unlike cholesterol, it's not something you can easily control with diet or exercise. It's a genetic gift that can lead to serious health issues, like heart disease and aortic stenosis. Most folks are famili
A recent study has brought disappointing news for those hoping to combat Alzheimer's disease. The drug semaglutide, known for its effectiveness in managing diabetes and obesity, did not show any significant benefits in slowing down the progression of Alzheimer's. This was revealed in two large-scale
Eli Lilly, a big name in the drug world, just hit a huge milestone. It became the first healthcare company to reach a market value of $1 trillion. That's a lot of money! The company's stock hit this mark briefly during trading but then settled a bit lower, with each share going for around $1, 048.
Creating new drugs is tough and expensive. Right now, scientists use flat cells or animals to test drugs, but these methods don't always work well for humans. That's where new tech comes in: tiny, 3D versions of human organs, called organoids, and special chips that mimic how organs work. These tool
A new book dives into how the life sciences industry can make big strides. It's not just about the science. The book talks about how the right people, good processes, and solid systems can make or break drug and device development. The author, a seasoned entrepreneur, shares his journey of building
Scientists have been digging into how clobenprobit (CB) and another compound, IT1t, work their magic to reduce inflammation. They've found that these compounds interact with a specific receptor in our bodies called CXCR4. This receptor is like a doorway that lets certain signals in, and CB and IT1t
Brain tumors, specifically glioma, are a big problem. They start in the support cells of the brain and can be very serious. Doctors have tried many treatments like surgery, drugs, and radiation, but these tumors often come back. So, what's going on? One key player in this is something called TGF-β.
Scientists have found a way to make a powerful microscope work better with tiny drug particles in water. This microscope, called a scanning electron microscope (SEM), usually needs a vacuum to work, but it can also be used to look at things in liquid. The problem is, small drug particles and other o
